Algo version: 0.98b
Invex Therapeutics Ltd is listed at the ASX Exchange
Invex Therapeutics Ltd [IXC.AX]
ASX Sector: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Is Invex Therapeutics Ltd stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Invex Therapeutics Ltd pays dividends. Last time was Monday 18th of December 2023 where the investors holding the stock on Friday 8th of December 2023 were paid $0.1863 per share. Over the last 1 times between 2023 and 2023, Invex Therapeutics Ltd has paid $0.1863 with an average of $0.19 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Invex Therapeutics Ltd 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $0.555, you would have made a loss of $-0.484 per share or -87.21%

No, the average daily trading liquidity for Invex Therapeutics Ltd is $34 373 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Invex Therapeutics Ltd has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Invex Therapeutics Ltd to be medium [0.7 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.